The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Articles|July 22, 2019
University of the Sciences Launches Cannabis MBA Program
Author(s)Megan L'Heureux
University of the Sciences announced a new program for students interested in the cannabis industry: a specialized Cannabis Industry Masters of Business Administration (MBA) option.
Advertisement
University of the Sciences (USciences, Philadelphia, Pennsylvania) announced a new program for students interested in the cannabis industry: a specialized Cannabis Industry Masters of Business Administration (MBA) option (1). Enrollment is currently open with online courses set to begin in September.
According the University, the coursework is an option of USciences’ specialized MBA in pharmaceutical and healthcare business, which is a hybrid curriculum with students taking courses online with occasional visits to campus. The “Cannabis Industry Option” MBA is reportedly the first of its kind in the U.S., offering education in the business of cannabis, hemp, and dispensary operations. The cannabis option was created in partnership with USciences’ Substance Use Disorders Institute as well as feedback from individuals in the industry. The option includes four elective courses specific to medical cannabis regulations and industry such as “Introduction to the Medical Cannabis Industry;” “Finance and Regulation in the Medical Cannabis Industry;” and “Cannabis Marketing and Sales.” There is also a project-based course where students will work to write a business plan or bring a product to market.
Andrew Peterson, executive director of the Substance Use Disorders Institute, who was integral in the creation of the courses explained that there are many unique aspects to the medical cannabis and hemp industries. “This new program will help to formalize those teachings for those currently in the cannabis industry, entering the field, or interested in other fields associated with the industry,” said Peterson.
“As the industry grows, and the potential for medical cannabis to converge with the pharmaceutical industry, a specialization in pharmaceutical and healthcare business will be an asset to those in the cannabis industry,” said Peterson. “A combination of healthcare, pharmaceutical, and cannabis business knowledge and expertise will be incredibly valuable as graduates move forward in their career.”
For more information about this new program visit
References:
Advertisement
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Advertisement
Advertisement